Does GOLIMUMAB Cause Malignant melanoma? 153 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 153 reports of Malignant melanoma have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.2% of all adverse event reports for GOLIMUMAB.
153
Reports of Malignant melanoma with GOLIMUMAB
0.2%
of all GOLIMUMAB reports
4
Deaths
16
Hospitalizations
How Dangerous Is Malignant melanoma From GOLIMUMAB?
Of the 153 reports, 4 (2.6%) resulted in death, 16 (10.5%) required hospitalization, and 3 (2.0%) were considered life-threatening.
Is Malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 153 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Malignant melanoma?
SILDENAFIL (1,248)
ADALIMUMAB (795)
TADALAFIL (741)
ETANERCEPT (495)
INFLIXIMAB (478)
METHOTREXATE (475)
DABRAFENIB (402)
LENALIDOMIDE (378)
RANITIDINE (352)
RITUXIMAB (291)
Which GOLIMUMAB Alternatives Have Lower Malignant melanoma Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN